WuXi’s weighs future of therapies unit

The Biosecure Act is forcing WuXi AppTec to assess the future of WuXi Advanced Therapies, its cell and gene therapies unit. WuXi blames the act—which prohibits US pharma and biotechnology companies from working with WuXi and other Chinese firms—for a 17% decline in WuXi Advanced’s revenue through the third quarter of this year. The company says it is assessing its options to ensure the continued operation of this business.

Authors

Publication Details

Journal
C&EN Global Enterprise
Published
2024-11-11
DOI
https://doi.org/10.1021/cen-10235-buscon16
Primary Topic
Science, Research, and Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

WuXi’s weighs future of therapies unit

Aayushi Pratap
C&EN Global Enterprise
Science, Research, and Medicine
article

WuXi’s weighs future of therapies unit

Aayushi Pratap
article en

Abstract

The Biosecure Act is forcing WuXi AppTec to assess the future of WuXi Advanced Therapies, its cell and gene therapies unit. WuXi blames the act—which prohibits US pharma and biotechnology companies from working with WuXi and other Chinese firms—for a 17% decline in WuXi Advanced’s revenue through the third quarter of this year. The company says it is assessing its options to ensure the continued operation of this business.

C&EN Global EnterpriseVol. 102(35)
Openalex Percentile: Top 70%
Science, Research, and Medicine
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

WuXi’s weighs future of therapies unit — Aayushi Pratap · C&EN Global Enterprise (2024) | TGRS Research Map | TGRS